Endothelial cells as a target for antiphospholipid antibodies: Role of anti-beta 2 glycoprotein I antibodies

American Journal of Reproductive Immunology

Volumn 38, Issue 3, 1997, Pages 212-217

  Del Papa, N ^a   Raschi, E ^a   Catelli, L ^a   Khamashta, M A ^b   Ichikawa, K ^b   Tincani, A ^c   Balestrieri, G ^c   Meroni, P L ^a,d  

^a UNIVERSITY OF MILAN   (Italy)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c Servizio di Immunologia Clinica   (Italy)

^d IRCCS   (Italy)

Author keywords

2 glycoprotein I; Adhesion molecules; Antiphospholipid antibodies; Cytokines; Endothelial cells; Thrombosis

Indexed keywords

BETA2 GLYCOPROTEIN 1; CELL ADHESION MOLECULE; INTERLEUKIN 1BETA; PHOSPHOLIPID ANTIBODY; POLYCLONAL ANTIBODY;

ANTIGEN BINDING; ARTICLE; ENDOTHELIUM CELL; LEUKOCYTE ADHERENCE; MONOLAYER CULTURE; PHENOTYPE; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; BLOOD COAGULATION; CELL ADHESION MOLECULES; CELL LINE; CELL MEMBRANE; ENDOTHELIUM, VASCULAR; GLYCOPROTEINS; HUMANS; THROMBOSIS;

EID: 0030880411     PISSN: 87558920     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Segovia AD, Sanchez Guerrero J: Primary antiphospholipid syndrome. J Rheumatol 1989; 16:426-428.
2. Hughes GRV: The antiphospholipid syndrome: Ten years on. Lancet 1993; 342:341-344.
3. Segovia AD: The pathophysiology of antiphospholipid antibodies. Semin Clin Immunol 1991; 1:11-19.
4. Triplett DA: Antiphospholipid antibodies: Proposed mechanisms of action. Ann J Reprod Immunol 1992; 28:211-215.
5. Roubey RAS: Autoantibodies to phospholipid-binding plasma proteins: A new view of lupus anticoagulant and other "antiphospholipid" autoantibodies. Blood 1994; 84:2854-2867.
6. Jaffe EA: Cell biology of endothelial cells. Hum Pathol 1987;18:234-241.
7. Gimbrone MA Jr: Vascular Endothelium in Hemostasis and Thrombosis. New York: Churchill Livingstone; 1986.
8. Carreras LO, Defreyn G, Machin SJ: Arterial thrombosis, intrauterine death and "lupus" anticoagulant. Detection of immunoglobulin interfering with prostacyclin formation. Lancet 1981; i: 244-246.
9. Carreras LO, Vermylen JG: Lupus anti-coagulant and thrombosis. Possible role of inhibition of prostacyclin formation. Thromb Haemost 1982; 48:38-40.
10. Vermylen JG, Arnout J: Is the antiphospholipid syndrome caused by antibodies directed against physiologically relevant phospholipid. J Lab Clin Med 1982; 120:10-12.
11. Meroni PL, Del Papa N, Gambini D, Tincani A, Balestrieri G: Antiphospholipid antibodies endothelial cells. Lupus 1994; 3:267-269.
12. Cariou R: Effect of lupus anticoagulant on antithrombogenic properties of endothelial cells. Inhibition of thrombo-modulin-dependent protein C activation. Thromb Haemost 1988; 60:54-58.
13. Carreras LO, Martinuzzo ME, Maclouf J: Anti-phospholipid antibodies, eicosanoids and expression of endothelial cyclooxygenase-2. Lupus 1996; 5:494-497.
14. Habib A, Martinuzzo M, Lebret M, Levy-Toledano S, Carreras LO, Maclouf J. Lupus anticoagulant IgGs do not depend on serum for the induction of cyclooxygenase-2 by human endothelial cells. In Advances in Prostaglandin, Thromboxane, and Leukotriene Research, B Samuelsson, R Paoletti, E Granstrom, PW Ramwell, G Folco, S Nicosia (eds). New York, Raven Press, 1993, pp 42-48.
15. Vismara A, Meroni PL, Tincani A, Harris EN, Barcellini W, Brucato A, Khamashta MA, Hughes GRV, Zanussi C, Balestrieri G: Relationship between anti-cardiolipin and antiendothelial cell antibodies in systemic lupus erythematosus. Clin Exp Immunol 1988; 74:247-253.
16. Hasselaar P, Derksen RHW, Blokzjil L, De Groot PG: Crossreactivity of antibodies directed against cardiolipin. DNA, endothelial cells and blood platelets. Thromb Haemost 1990; 63:169-173.
17. Cervera R, Khamashta MA, Font J, Ramirez G, D'Cruz D, Montalban J, Lopez-Soto A, Asherson RA, Ingelmo M, Hughes GRV: Antiendothelial cell antibodies in patients with the antiphospholipid syndrome. Autoimmunity 1991; 11:1-6.
18. MacCrae KR, De Michele A, Samuels P, Roth D, Kuo A, Meng QH, Rauch J, Cines DA: Detection of endothelial cell-reactive immunoglobulin in patients with anti-phospholipid antibodies. Br J Haematol 1991; 79:595-605.
19. Del Papa N, Meroni PL, Tincani A, Harris EN, Pierangeli SS, Barcellini W, Borghi MO, Balestrieri G, Zanussi C: Relationship between antiphospholipid and antiendothelial antibodies: Further characterization of the reactivity on resting and cytokine-activated endothelial cells. Clin Exp Rheumatol 1992; 10:37-42.
20. McNeil HP, Simpson RJ, Chesterman CN, Krilis SA: Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: β2glycoprotein I (apolipoprotein H). Proc Natl Acad Sci U S A 1990; 87:4120-4124.
21. Galli M, Comfurius P, Maasen C, Hemker HC, de Baets MH, Van Breida-Vrieasman PJC, Barbui T, Beevers EM: Anticardiolipin antibodies (ACA) are directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990; 335:1544-1547.
22. Arvieaux J, Roussel B, Jacob MC, Columb MG: Measurement of anti-phospholipid antibodies by ELISA using β2-glycoprotein I as antigen. J Immunol Methods 1991; 143:223-229.
23. Viard JP, Amoura Z, Bach JF: Association of anti-β2-glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus. Am J Med 1992; 93:181-186.
24. Cabiedes J, Cabral AR, Alarcon-Segovia D: Clinical manifestations of antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-β2-glycoprotein I than with anti-phospholipid antibodies. J Rheumatol 1995; 22:1899-1906.
25. Balestrieri G, Tincani A, Spatola L, Allegri F, Prati E, Cattaneo R, Valesini G, Del Papa N, Meroni PL: Anti-β2-glycoprotein I antibodies I: A marker of anti-phospholipid syndrome. Lupus 1995; 4:122-130.
26. Alarcon-Segovia D, Cabral AR: The Anti-phospholipid/Co-factor Syndromes. J Rheumatol 1996; 23:1319-1322.
27. Shousboe I: β2-glycoprotein I: A plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway. Blood 1985; 66:1086-1091.
28. Nimpf J, Wurm H, Kostner GM: β2-glycoprotein I (apo-H) inhibits the release reaction of human platelets during ADP-induced aggregation. Atherosclerosis 1987; 63:109-114.
29. Vazquez-Mellado J, Llorente L, Richaud-Patin Y, Alarcon-Segovia D: Exposure of anionic phospholipids upon platelet activation permits binding of β2-glycoprotein I and through it that of IgG antiphospholipid antibodies. Studies in platelets from patients with antiphospholipid syndrome and normal subjects. J Autoimmun 1994; 12:122-131.
30. Del Papa N, Conforti G, Gambini D, Barcellini W, Borghi MO, Fain C, Tincani A, Balestrieri G, Tedesco F, Meroni PL: Characterisation of antiendothelial cell antibodies in anti-phospholipd syndrome. In Molecular Basis of Human Diseases, EE Polli (ed). Amsterdam, London, New York, Tokyo, Excerpta Medica, 1993.
31. Mc Intyre JA: Immune recognition at the maternal-fetal interface: Overview. Am J Reprod Immunol 1992; 28: 127-131.
32. La Rosa L, Meroni PL, Tincani A, Balestrieri G, Faden A, Lojacono A, Morassi L, Brocchi E, Del Papa N, Gharavi AE, Sammaritano L, Lockshin MD: β2-glycoprotein I and placental anticoagulant protein I in placentae from patients with anti-phospholipid syndrome. J Rheumatol 1994; 21:1684-1698.
33. Van WY, Mac Crae KR: β2-glycoprotein I binds specifically to human endothelial cells. Lupus 1996; 5:504.
34. Del Papa N, Guidali L, Spatola L, Bonara P, Borghi MO, Tincani A, Balestrieri G, Meroni PL: Relationship between anti-phospholipid and anti-endothelial cell antibodies III: β2-glycoprotein I mediates the antibody binding to endothelial membranes and induces the expression of adhesion molecules. Clin Exp Rheumatol 1995; 13:179-186.
35. Le Tonqueze M, Dueymes M, Piette JC: Is there a role for β2-glycoprotein I in the anti-phospholipid antibody binding to endothelial cells? Lupus 1995; 4:179-186.
36. Simantov R, LaSala JM, Lo SK, Gharavi AE, Sammaritano LR, Salmon JE, Silverstein RL: Activation of cultured vascular endothelial cells by antiphospholipid antibodies. J Clin Invest 1995; 96:2211-2219.
37. Del Papa N, Guidali L, Sala A, Buccellati C, Khamashta MA, Ichikawa K, Koike T, Balestrieri G, Tincani A, Meroni PL: Endothelial cells as target for anti-phospholipid antibodies: Human polyclonal and monoclonal anti- b2-glycoprotein I antibodies react in vitro with endothelial cells through adherent b2-glycoprotein I and induces endothelial activation. Arthritis Rheum 1996; in press.
38. Meroni PL, D'Cruz D, Khamashta MA, Yoinou P, Hughes GRV: Anti-endothelial cell antibodies : Only for scientists or for clinicians too? Clin Exp Immunol 1996; 104:199-202.
39. Ichikawa K, Khamashta MA, Koike T, Matsuura E, Hughes GRV: 2-glycoprotein I reactivity of monoclonal anticardiolipin antibodies from patients with the antiphospholipid syndrome. Arthritis Rheum 1994; 37:1453-1461.
40. Bevilacqua MP, Pober JS, Wheeler ME, Cotran RS, Gimbrone MA: Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorpho-nuclear leukocytes, monocytes and related leukocyte cell lines. J Clin Invest 1985; 76:2003-2011.
41. Nawrot P, Stern D. Endothelial cell procoagulant properties and the host response. Semin Thromb Hemost 1987; 13:391-398.
42. Carlos TM, Harlan JM: Leukocyte-endothelial adhesion molecules. Blood 1994; 84:2068-2101.
43. Kornberg A, Blank M, Kaufman S, Shoenfeld Y: Induction of tissue factor-like activity in monocytes by anticardiolipin antibodies. J Immunol 1994; 153:1328-1331.
44. Alarcon-Segovia D, Cardiel MH, Reyes E: Antiphospholipid arterial vasculopathy. J Rheumatol 1989; 16:762-767.
45. Goldenberg E, Elder RC, Schwartz RA, Phillips PE: Vasculitis in the antiphospholipid syndrome. Arthritis Rheum 1992; 33:569-572.
46. Roberts WN, De Meo JH, Breitbach SA: Well-imaged large vessel vasculitis attributed to anticardiolipin antibody. Arthritis Rheum 1994; 8:1254-1257.
47. Lie JT: Vasculitis in the antiphospholipid syndrome: Culprit or consort? J Rheumatol 1994; 21:397-399.
48. Lellouche F, Martinuzzo ME, Said P, Maclouf J, Carreras LA: Imbalance of thromboxane/prostacyclin biosynthesis in patients with lupus anticoagulant. Blood 1991; 78: 2894-2899.